Systemic BP and heart rate as prognostic indicators in pulmonary arterial hypertension

Chest

Volumn 144, Issue 3, 2013, Pages 959-965

  Bersohn, Malcolm M ^a   Turner, Michelle P ^b   Traiger, Glenna L ^a   Frost, Adaani E ^c   Shapiro, Shelley ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ICON Late Phase and Outcomes Research   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART RATE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL PREDICTION; SURVIVAL RATE;

EID: 84884341881     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2572     Document Type: Article

References (15)

1. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006 ; 113 (11): 1424-1433.
2. Komajda M, Carson PE, Hetzel S, et al. Factors associated with outcome in heart failure with preserved ejection fraction: fi ndings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail. 2011; 4 (1): 27-35.
3. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006 ; 27 (1): 65-75.
4. Wedel H, McMurray JJ, Lindberg M, et al ; CORONA Study Group. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, highsensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail. 2009 ; 11 (3): 281-291.
5. Abraham WT, Fonarow GC, Albert NM, et al ; OPTIMIZE-HF Investigators and Coordinators. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008 ; 52 (5): 347-356.
6. Böhm M, Swedberg K, Komajda M, et al; SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010 ; 376 (9744): 886-894.
7. McLaughlin VV, Archer SL, Badesch DB, et al ; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, Amer ican Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009 ; 119 (16): 2250-2294.
8. Galiè N, Hoeper MM, Humbert M, et al ; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009 ; 30 (20): 2493-2537.
9. McLaughlin VV, Presberg KW, Doyle RL, et al ; American College of Chest Physicians. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 ; 126 (1)(suppl): 78S-92S.
10. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010 ; 122 (2): 164-172.
11. McGoon MD, Krichman A, Farber HW, et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008 ; 83 (8): 923-931.
12. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010 ; 137 (2): 376-387.
13. Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012 ; 141 (2): 363-373.
14. Frost AE, Farber HW, Barst RJ, et al. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures of 16-18 mmHg: Insights from REVEAL. Chest. 2013 ; 143 (1): 185-195.
15. Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL Registry risk score calculator in patients newly diag nosed with pulmonary arterial hypertension. Chest. 2012; 141(2): 354-362.